Seasoned global pharmaceutical executive, Mr Brent MacGregor, joins Vaxxas Board to accelerate self-administered HD-MAP vaccines for global use;SPRIM Global Investment’s Co-Founder and Managing ...
With rapid advancements in whole genome sequencing, Kadam noted that genetic science is moving toward even more comprehensive ...
The data, which is being presented at this year's AMP meeting, offers some insights into the often hidden causes of recurrent pregnancy loss.
A new technology may allow patients to recover vision for conditions that were previously thought irreversible ...
News-Medical.Net on MSN
Uncovering hidden causes of recurrent pregnancy loss with optical genome mapping
Pregnancy loss may occur in as many as 25% of all pregnancies. Most of these losses occur in the first trimester, and about ...
Researchers at Dartmouth–Hitchcock Medical Center investigated whether OGM could detect harmful chromosomal changes in patients with a family history or risk of recurrent pregnancy loss who had ...
Pfizer has fended off Nova Nordisk for control of the next-gen weight-loss drug developer Metsera. Meanwhile, Resmed watches ...
OGT expands MRD detection capabilities with new SureSeq Myeloid MRD Plus NGS Panel: Oxford, UK Wednesday, November 12, 2025, 17:00 Hrs [IST] Oxford Gene Technology (OGT), a Sysmex ...
A multi-disciplinary approach was employed, using a combination of multiomic techniques, including single-cell RNA-sequencing ...
Federal judge rules divestiture plan addresses competition concerns in GTCR's acquisition of Surmodics despite FTC claims of ...
Pregnancy loss may occur in as many as 25% of all pregnancies. Most of these losses occur in the first trimester, and about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback